OBJECTIVE: To evaluate the hypothesis that elevated levels of inflammation-related proteins in early postnatal blood predict impaired mental and motor development in extremely preterm infants. STUDY DESIGN: We measured concentrations of 25 inflammation-related proteins in blood collected on postnatal days 1, 7, and 14 from 939 infants born before 28 weeks gestation. An elevated level was defined as a concentration in the highest quartile for gestational age and day of blood collection. We identified impaired development at age 24 months using the Bayley Scales of Infant Development, Second Edition. The primary outcomes were scores on the Mental Scale or the Motor Scale of <55 (more than 3 SDs below the mean). RESULTS: For 17 of the 25 inflammation-related proteins, 1 or more statistically significant associations (P<.01) was found between an elevated blood level of the protein and a developmental impairment. Elevations on multiple days were more often associated with developmental impairment than were elevations present for only 1 day. The highest number of predictive elevations was found in day-14 blood. CONCLUSION: In extremely preterm infants, elevated levels of inflammation-related proteins in blood collected on postnatal days 7 and 14, especially when sustained, are associated with impaired mental and motor development at age 2 years. Copyright Â
OBJECTIVE: To evaluate the hypothesis that elevated levels of inflammation-related proteins in early postnatal blood predict impaired mental and motor development in extremely preterm infants. STUDY DESIGN: We measured concentrations of 25 inflammation-related proteins in blood collected on postnatal days 1, 7, and 14 from 939 infants born before 28 weeks gestation. An elevated level was defined as a concentration in the highest quartile for gestational age and day of blood collection. We identified impaired development at age 24 months using the Bayley Scales of Infant Development, Second Edition. The primary outcomes were scores on the Mental Scale or the Motor Scale of <55 (more than 3 SDs below the mean). RESULTS: For 17 of the 25 inflammation-related proteins, 1 or more statistically significant associations (P<.01) was found between an elevated blood level of the protein and a developmental impairment. Elevations on multiple days were more often associated with developmental impairment than were elevations present for only 1 day. The highest number of predictive elevations was found in day-14 blood. CONCLUSION: In extremely preterm infants, elevated levels of inflammation-related proteins in blood collected on postnatal days 7 and 14, especially when sustained, are associated with impaired mental and motor development at age 2 years. Copyright Â
Authors: Alan Leviton; Karl Kuban; T Michael O'Shea; Nigel Paneth; Raina Fichorova; Elizabeth N Allred; Olaf Dammann Journal: J Pediatr Date: 2011-01-15 Impact factor: 4.406
Authors: Shefali Talwar; Peter J Munson; Jennifer Barb; Carmen Fiuza; Anadel Pilar Cintron; Carolea Logun; Margaret Tropea; Sameena Khan; Debra Reda; James H Shelhamer; Robert L Danner; Anthony F Suffredini Journal: Physiol Genomics Date: 2006-01-10 Impact factor: 3.107
Authors: Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet Journal: Neuroscience Date: 2017-01-09 Impact factor: 3.590
Authors: Martha Scott Tomlinson; Kun Lu; Jill R Stewart; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry Journal: Clin Microbiol Rev Date: 2019-05-01 Impact factor: 26.132
Authors: Marliese Dion Nist; Rita H Pickler; Tondi M Harrison; Deborah K Steward; Abigail B Shoben Journal: Early Hum Dev Date: 2020-05-22 Impact factor: 2.079
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Elizabeth T Jensen; Jelske W van der Burg; Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; Tim Heeren; Alan Leviton; Karl C K Kuban Journal: J Pediatr Date: 2017-03-21 Impact factor: 4.406
Authors: Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; Karl K C Kuban Journal: Early Hum Dev Date: 2018-02-07 Impact factor: 2.079
Authors: Michael W Varner; Maged M Costantine; Kathleen A Jablonski; Dwight J Rouse; Brian M Mercer; Kenneth J Leveno; Uma M Reddy; Catalin Buhimschi; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Mary J O'sullivan; Alan M Peaceman; Donald J Dudley; Steve N Caritis Journal: Am J Perinatol Date: 2019-02-07 Impact factor: 1.862
Authors: Poojitha Matta; Stacy D Sherrod; Christina C Marasco; Daniel J Moore; John A McLean; Joern-Hendrik Weitkamp Journal: J Immunol Date: 2017-09-25 Impact factor: 5.422
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079